About the Editors



Hillard M. Lazarus, USA

Hillard Lazarus is Professor of Medicine and Director of Novel Cell Therapies at Case Western Reserve University, University Hospitals Case Medical Center, where he is The George & Edith Richman Professor & Distinguished Scientist in Cancer Research. Dr. Lazarus is recognized for his contributions in the areas of mesenchymal stem cell transplantation, autologous blood and marrow transplantation for lymphoma, and allogeneic blood and marrow transplantation for malignancies. He has over 500 publications and has been a committed teacher and mentor to countless house officers, fellows and faculty.

Mohamad Mohty, France

Mohamad Mohty is Professor of Hematology and head of the Hematology and cellular therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie (Paris, France). Professor Mohty is also head of a translational research team (INSERM) at the Saint-Antoine Research centre in Paris and his research is focused on the pathophysiology and immunobiology of normal and pathological antigen-presenting cells, especially the impact of immunomodulatory agents. He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of multiple myeloma. Professor Mohty is currently president of the European Society for Blood and Marrow Transplantation (EBMT). He serves on the board of the EBMT, and the “Intergroupe Francophone du Myelome” (IFM).

Executive Editor

Robert Peter Gale, USA

Deputy Editors

Jane Apperley, UK 
Armand Keating, Canada
Alejandro Madrigal, UK
Yair Reisner, Israel

Associate Editors

Karen Ballen, USA 
A. John Barrett, USA 
Ali Bazarbachi, Lebanon
Ed Copelan, USA
Jan Cornelissen, Netherlands
Marcelo Fernandez-Vina, USA
Sergio Giralt, USA 
Rupert Handgretinger, Germany 
Per Ljungman, Sweden 
Arnon Nagler, Israel 
Jakob Passweg, Switzerland 
Pavan Reddy, USA
Bipin Savani, USA 
Takanori Teshima, Japan 
Marcie Riches, USA
Mei-Jie Zhang, USA